SEC Form 4 · accession 0001567619-18-005447
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Richard
Director
Period of report
Nov 7, 2018
Accepted (ET)
Nov 8, 2018 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 7, 2018 | M | 7,893 | $13.00 | A | 28,856 | D | |
| Common StockF1 | Nov 7, 2018 | S | 7,893 | $70.00 | D | 20,963 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1,F3 | $13.00 | Nov 7, 2018 | M | 7,893 | D | — | May 22, 2020 | Comon Stock | 7,893 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.
- F2Consists of an option granted under the company's stock incentive plan as amended and restated.
- F3The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.